UBS Group’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.27M | Sell |
60,400
-114,600
| -65% | -$8.58M | ﹤0.01% | 4232 |
|
|
2025
Q4 | $13.8M | Sell |
175,000
-7,700
| -4% | -$609K | ﹤0.01% | 2955 |
|
|
2025
Q3 | $15M | Hold |
182,700
| – | – | ﹤0.01% | 2881 |
|
|
2025
Q2 | $14.7M | Sell |
182,700
-54,900
| -23% | -$4.24M | ﹤0.01% | 2695 |
|
|
2025
Q1 | $19.1M | Sell |
237,600
-70,000
| -23% | -$5.82M | ﹤0.01% | 2376 |
|
|
2024
Q4 | $25.2M | Buy |
307,600
+25,200
| +9% | +$2.1M | ﹤0.01% | 2097 |
|
|
2024
Q3 | $23.3M | Buy |
282,400
+63,500
| +29% | +$4.74M | 0.01% | 1704 |
|
|
2024
Q2 | $15.4M | Sell |
218,900
-2,500
| -1% | -$178K | ﹤0.01% | 1891 |
|
|
2024
Q1 | $16.4M | Sell |
221,400
-941,500
| -81% | -$65.6M | ﹤0.01% | 1852 |
|
|
2023
Q4 | $76.9M | Buy |
1,162,900
+89,200
| +8% | +$5.58M | 0.02% | 719 |
|
|
2023
Q3 | $67.5M | Buy |
1,073,700
+36,770
| +4% | +$2.29M | 0.02% | 678 |
|
|
2023
Q2 | $58.6M | Sell |
1,036,930
-609,570
| -37% | -$33.8M | 0.02% | 743 |
|
|
2023
Q1 | $95.4M | Buy |
1,646,500
+381,400
| +30% | +$25.7M | 0.03% | 476 |
|
|
2022
Q4 | $91.6M | Buy |
1,265,100
+25,000
| +2% | +$1.79M | 0.03% | 519 |
|
|
2022
Q3 | $75.4M | Buy |
1,240,100
+305,700
| +33% | +$19.5M | 0.03% | 524 |
|
|
2022
Q2 | $58.7M | Buy |
934,400
+678,900
| +266% | +$44.9M | 0.02% | 648 |
|
|
2022
Q1 | $18M | Sell |
255,500
-395,500
| -61% | -$26.7M | 0.01% | 1512 |
|
|
2021
Q4 | $40.7M | Buy |
651,000
+228,089
| +54% | +$14.3M | 0.01% | 1084 |
|
|
2021
Q3 | $26.1M | Buy |
422,911
+67,200
| +19% | +$4.05M | 0.01% | 1298 |
|
|
2021
Q2 | $21.3M | Buy |
355,711
+14,100
| +4% | +$894K | 0.01% | 1446 |
|
|
2021
Q1 | $20.8M | Buy |
341,611
+127,611
| +60% | +$7.04M | 0.01% | 1427 |
|
|
2020
Q4 | $10M | Hold |
214,000
| – | – | ﹤0.01% | 1844 |
|
|
2020
Q3 | $7.95M | Sell |
214,000
-90,000
| -30% | -$3.42M | ﹤0.01% | 1814 |
|
|
2020
Q2 | $11.1M | Buy |
304,000
+90,000
| +42% | +$3.13M | ﹤0.01% | 1426 |
|
|
2020
Q1 | $6.54M | Sell |
214,000
-1,588,800
| -88% | -$70.5M | ﹤0.01% | 1712 |
|
|
2019
Q4 | $91.9M | Buy |
1,802,800
+1,543,800
| +596% | +$74.5M | 0.03% | 480 |
|
|
2019
Q3 | $12.2M | Buy |
259,000
+48,000
| +23% | +$2.29M | ﹤0.01% | 1610 |
|
|
2019
Q2 | $10.5M | Buy |
211,000
+144,000
| +215% | +$6.77M | ﹤0.01% | 1717 |
|
|
2019
Q1 | $2.85M | Buy |
+67,000
| New | +$2.96M | ﹤0.01% | 2668 |
|
|
2018
Q4 | – | Sell |
-58,000
| Closed | -$2.71M | – | 8193 |
|
|
2018
Q3 | $2.71M | Buy |
+58,000
| New | +$2.65M | ﹤0.01% | 2931 |
|
|
2018
Q2 | – | Sell |
-52,100
| Closed | -$2.39M | – | 8148 |
|
|
2018
Q1 | $2.39M | Sell |
52,100
-156,100
| -75% | -$7.57M | ﹤0.01% | 2990 |
|
|
2017
Q4 | $10.5M | Buy |
+208,200
| New | +$11M | ﹤0.01% | 1675 |
|
|
2017
Q2 | – | Sell |
-12,791
| Closed | -$602K | – | 7855 |
|
|
2017
Q1 | $602K | Sell |
12,791
-714,377
| -98% | -$34.1M | ﹤0.01% | 3911 |
|
|
2016
Q4 | $34.9M | Sell |
727,168
-1,618,597
| -69% | -$74.2M | 0.02% | 706 |
|
|
2016
Q3 | $92.9M | Buy |
2,345,765
+45,665
| +2% | +$1.72M | 0.06% | 340 |
|
|
2016
Q2 | $81.7M | Sell |
2,300,100
-1,223,653
| -35% | -$47.7M | 0.05% | 356 |
|
|
2016
Q1 | $138M | Sell |
3,523,753
-253,684
| -7% | -$9.48M | 0.09% | 223 |
|
|
2015
Q4 | $162M | Buy |
3,777,437
+3,771,939
| +68,606% | +$166M | 0.11% | 206 |
|
|
2015
Q3 | $231K | Sell |
5,498
-12,678
| -70% | -$592K | ﹤0.01% | 4513 |
|
|
2015
Q2 | $907K | Buy |
18,176
+1,234
| +7% | +$58.4K | ﹤0.01% | 3652 |
|
|
2015
Q1 | $763K | Sell |
16,942
-309,066
| -95% | -$13.9M | ﹤0.01% | 3804 |
|
|
2014
Q4 | $15.7M | Buy |
+326,008
| New | +$15.5M | 0.01% | 1158 |
|
Other funds holding MET
VCM
VPM
UBS Group's MET Position: Q1 2026 in Review
UBS Group increased its MetLife (MET) stake by 46% in Q1 2026, buying an estimated $85.4M and bringing the position to 3,605,168 shares worth $255M. The position accounts for 0.04% of the portfolio, ranked #500.
UBS Group first reported a position in MET in Q4 2014 and has held it in 46 quarters since. The position peaked at $293M in Q4 2014. 1,372 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- UBS Group held 3,605,168 shares of MetLife worth $255M as of Q1 2026.
- UBS Group bought 1,140,426 MetLife shares in Q1 2026, an estimated $85.4M.
- MetLife made up 0.04% of UBS Group's portfolio in Q1 2026, its #500 holding.
- UBS Group first reported a position in MetLife in Q4 2014 and has held it in 46 quarters since.
- UBS Group's MetLife position peaked at $293M in Q4 2014.
- 1,372 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.